Search for susceptibility genes in primary sclerosing cholangitis

Research news

In humans, genetic studies and the search for susceptibility genes are of utmost importance

as their principle goal is to define defective biological pathways implicated in certain pathologies.  Such an approach was recently published in the journal Gastroenterology and focused on primary sclerosing cholangitis, or PSC, a disease very closely related to  IBD.  PSC is a liver disease characterized by chronic inflammation with fibrosis and gradual destruction of the intra- and extrahepatic bile ducts.  In 75% of cases, it is associated with   UC.  It is an important risk factor in the development of colon cancer (risk multiplied by 5) and, in the USA, is the 5th most frequent reason for liver transplantation.  The etiology of PSC is unknown  and the demonstration of susceptibility genes potentially involved in this pathology could provide crucial information on the onset and development of the disease.  Results obtained in different European cohorts show a strong association between certain genes coding for histocompatibility proteins and the risk of developing PSC.  Three other chromosomal regions would appear to be associated with a higher risk of developing  PSC, two of which had been previously identified during similar studies on UC.   Nevertheless, this work did not enable precise identification of genes potentially involved in PSC, though it did point out several genes suspected to play an important role in bile metabolism and the inflammatory response.  Moreover, among 15 susceptibility genes identified for UC, only two were found for PSC, confirming that the  chronic intestinal inflammation associated with PSC presents clinical manifestations which are clearly distinct from those of the other IBD.  This study, along with future functional studies of the genes identified here and which are suspected to be involved in PSC, should lead to a better understanding of the physiopathology of PSC.  Nonetheless, this disease  continues to remain a mystery, and new studies will be necessary in order to identify its causes and mechanisms.

 

Genome-Wide Association analysis in Primary Sclerosing Cholangitis, Tom H. Karlsen et al. Gastroenterology, 2010, article in press

 

Subscribe to our newsletter!
Newsletter en français
Newsletter in english

Peut-on arrêter un traitement par Anti-TNF ?

Une étude prospective récente effectuée par le GETAID (Groupe d’Etude Thérapeutique des Affections Inflammatoires du Tube Digestif) appelée Stori

Read more…


Your employer appreciates your treatment !

The effect of adalimumab upon work productivity

Read more…


Children with Crohn’s disease

What is their outcome ?

Read more…